Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats

Journal of Neurotrauma

Volumn 28, Issue 10, 2011, Pages 2123-2134

  Wang, Guo Hua ^a,b   Jiang, Zheng Lin ^a   Li, Yong Cai ^c   Li, Xia ^a   Shi, Hong ^b   Gao, Yan Qin ^b   Vosler, Peter S ^d   Chen, Jun ^b,d  

^a NANTONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Ningxia Eye Hospital   (China)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

edaravone; inflammatory cytokines; neuroprotection; oxidative stress; TBI

Indexed keywords

FREE RADICAL; NORPHENAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN NERVE CELL; CELL LOSS; GLIA; HIPPOCAMPUS; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; TRAUMATIC BRAIN INJURY;

ANIMALS; ANTIPYRINE; APOPTOSIS; ASTROCYTES; BLOOD-BRAIN BARRIER; BODY WATER; BRAIN INJURIES; COLORING AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREE RADICAL SCAVENGERS; FREE RADICALS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICROGLIA; MICROSCOPY, ELECTRON; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80054722837     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2011.1939     Document Type: Article

References (46)

1. Aarabi, B., and Simard, J. M. (2009). Traumatic brain injury. Curr. Opin. Crit. Care 15, 548-553
2. Besson, V. C. (2009). Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation. Br J Pharmacol 157, 695-704.
3. Chew, E., and Zafonte, R. D. (2009). Pharmacological management of neurobehavioral disorders following traumatic brain injury-a state-of-the-art review. J. Rehabil. Res. Dev. 46, 851-879.
4. Chua, K. S., Ng, Y. S., Yap, S. G., and Bok, C. W. (2007). A brief review of traumatic brain injury rehabilitation. Ann. Acad. Med. Singapore 36, 31-42. (Pubitemid 46512456)
5. Clausen, F., Lundqvist, H., Ekmark, S., Lewen, A., Ebendal, T., and Hillered, L. (2004). Oxygen free radical-dependent activation of extracellular signal-regulated kinase mediates apo-ptosis-like cell death after traumatic brain injury. J. Neurotrauma 21, 1168-1182. (Pubitemid 39280844)
6. Clausen, F., Marklund, N., Lewen, A., and Hillered, L. (2008). The nitrone free radical scavenger NXY-059 is neuroprotective when administered after traumatic brain injury in the rat. J. Neurotrauma 25, 1449-1457.
7. Dohi, K., Satoh, K., Mihara, Y., Nakamura, S., Miyake, Y., Oh-taki, H., Nakamachi, T., Yoshikawa, T., Shioda, S., and Aruga, T. (2006). Alkoxyl radical-scavenging activity of edaravone in patients with traumatic brain injury. J. Neurotrauma 23, 1591-1599. (Pubitemid 44846654)
8. Dohi, K., Satoh, K., Nakamachi, T., Yofu, S., Hiratsuka, K., Na-kamura, S., Ohtaki, H., Yoshikawa, T., Shioda, S., and Aruga, T. (2007). Does edaravone (MCI-186) act as an antioxidant and a neuroprotector in experimental traumatic brain injury? Antioxid. Redox Signal. 9, 281-287. (Pubitemid 46105426)
9. Eghwrudjakpor, P. O., and Allison, A. B. (2010). Oxidative stress following traumatic brain injury: enhancement of endogenous antioxidant defense systems and the promise of improved outcome. Niger. J. Med. 19, 14-21.
10. Gilgun-Sherki, Y., Rosenbaum, Z., Melamed, E., and Offen, D. (2002). Antioxidant therapy in acute central nervous system injury: current state. Pharmacol. Rev. 54, 271-284. (Pubitemid 34575717)
11. Gottesfeld, Z., Moore, A. N., and Dash, P. K. (2002). Acute ethanol intake attenuates inflammatory cytokines after brain injury in rats: a possible role for corticosterone. J. Neuro-trauma 19, 317-326. (Pubitemid 34246119)
12. Greve, M. W., and Zink, B. J. (2009). Pathophysiology of traumatic brain injury. Mt. Sinai J. Med. 76, 97-104.
13. Griesser, M., Boeglin, W.E., Suzuki, T., and Schneider, C. (2009). Convergence of the 5-LOX and COX-2 pathways: heme-catalyzed cleavage of the 5S-HETE-derived di-endoperoxide into aldehyde fragments. J. Lipid Res. 50, 2455-2462.
14. Hall, E. D., Vaishnav, R. A., and Mustafa, A. G. (2010). Anti-oxidant therapies for traumatic brain injury. Neurother-apeutics 7, 51-61.
15. Hanisch, U. K. (2002). Microglia as a source and target of cyto-kines. Glia 40, 140-155.
16. Hill, S. J., Barbarese, E., and McIntosh, T. K. (1996). Regional heterogeneity in the response of astrocytes following traumatic brain injury in the adult rat. J. Neuropathol. Exp. Neu-rol. 55, 1221-1229. (Pubitemid 26397141)
17. Itoh, T., Satou, T., Nishida, S., Tsubaki, M., Imano, M., Hashimoto, S., and Ito, H. (2010). Edaravone protects against apoptotic neuronal cell death and improves cerebral function after traumatic brain injury in rats. Neurochem. Res. 35, 348-355.
18. Kikuchi, K., Kawahara, K., Miyagi, N., Uchikado, H., Kuramoto, T., Morimoto, Y., Tancharoen, S., Miura, N., Takenouchi, K., Oyama, Y., Shrestha, B., Matsuda, F., Yoshida, Y., Arimura, S., Mera, K., Tada, K., Yoshinaga, N., Maenosono, R., Ohno, Y., Hashiguchi, T., Maruyama, I., and Shigemori, M. (2010). Edaravone: a new therapeutic approach for the treatment of acute stroke. Med. Hypotheses 75, 583-585.
19. Kossmann, T., Hans, V. H., Imhof, H. G., Stocker, R., Grob, P., Trentz, O., and Morganti-Kossmann, C. (1995). Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries Shock 4, 311-317.
20. Laird, M. D., Vender, J. R., and Dhandapani, K. M. (2008). Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 16, 154-164. (Pubitemid 351263222)
21. Lapchak, P. A. (2010). A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuro-protective therapy? Expert Opin. Pharmacother. 11, 1753-1763.
22. Lu, J., Goh, S. J., Tng, P. Y., Deng, Y. Y., Ling, E. A., and Moochhala, S. (2009). Systemic inflammatory response following acute traumatic brain injury. Front. Biosci. 14, 3795-3813.
23. Maas, A. I., Stocchetti, N., and Bullock, R. (2008). Moderate and severe traumatic brain injury in adults. Lancet Neurol. 7, 728-741. (Pubitemid 351957931)
24. Margaill, I., Plotkine, M., and Lerouet, D. (2005). Antioxidant strategies in the treatment of stroke. Free Radic. Biol. Med. 39, 429-443. (Pubitemid 41021642)
25. Merenda, A., Gugliotta, M., Holloway, R., Levasseur, J. E., Alessandri, B., Sun, D., and Bullock, M. R. (2008). Validation of brain extracellular glycerol as an indicator of cellular membrane damage due to free radical activity after traumatic brain injury. J. Neurotrauma 25, 527-537. (Pubitemid 351685484)
26. Naritomi, H., Moriwaki, H., Metoki, N., Nishimura, H., Higashi, Y., Yamamoto, Y., Yuasa, H., Oe, H., Tanaka, K., Saito, K., Terayama, Y., Oda, T., Tanahashi, N., and Kondo, H. (2010). Effects of edaravone on muscle atrophy and locomotor function in patients with ischemic stroke: a randomized controlled pilot study. Drugs R D 10, 155-163.
27. Pearse, D., and Jarnagin, K. (2010). Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies. Curr. Opin. Investig. Drugs 11, 1207-1210.
28. Petronilho, F., Feier, G., de Souza, B., Guglielmi, C., Constantino, L. S., Walz, R., Quevedo, J., and Dal-Pizzol, F. (2010). Oxida-tive stress in brain according to traumatic brain injury intensity. J. Surg. Res. 164, 316-320.
29. Regan-Shaw, S., Nihal, M., and Ahmad, N. (2008). Dose translation from animal to human studies revisited. FASEB J. 22, 59-61.
30. Serrano-Perez, M. C., Martin, E. D., Vaquero, C. F., Azcoitia, I., Calvo, S., Cano, E., and Tranque, P. (2011). Response of transcription factor NFATc3 to excitotoxic and traumatic brain insults: identification of a subpopulation of reactive astrocytes. Glia 59, 94-107.
31. Shlosberg, D., Benifla, M., Kaufer, D., and Friedman, A. (2010). Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol. 6, 393-403.
32. Sofroniew, M. V. (2009). Molecular dissection of reactive astro-gliosis and glial scar formation. Trends Neurosci. 32, 638-647.
33. Spickett, C.M., Wiswedel, I., Siems, W., Zarkovic, K., and Zarkovic, N. (2010). Advanced in methods for the determination of biologically relevant lipid peroxidation products. Free Radic. Res. 44, 1172-1202.
34. Stoica, B. A., and Faden, A. I. (2010). Cell death mechanisms and modulation in traumatic brain injury. Neurotherapeutics 7, 3-12.
35. Stoll, G., and Jander, S. (1999). The role of microglia and mac-rophages in the pathophysiology of the CNS. Prog. Neurobiol. 58, 233-247. (Pubitemid 29193056)
36. Tacconi, M. T. (1998). Neuronal death: is there a role for astro-cytes? Neurochem. Res. 23, 759-765. (Pubitemid 28173583)
37. Vajtr, D., Benada, O., Kukacka, J., Prusa, R., Houstava, L., Toupalik, P., and Kizek, R. (2009). Correlation of ultrastruc-tural changes of endothelial cells and astrocytes occurring during blood brain barrier damage after traumatic brain injury with biochemical markers of BBB leakage and inflammatory response. Physiol. Res. 58, 263-268.
38. Venters, H. D., Dantzer, R., and Kelley, K. W. (2000). A new concept in neurodegeneration: TNFalpha is a silencer of survival signals. Trends Neurosci. 23, 175-180. (Pubitemid 30151214)
39. Vosler, P. S., and Chen, J. (2009). Potential molecular targets for translational stroke research. Stroke 40, S119-120.
40. Vosler, P. S., Sun, D., Wang, S., Gao, Y., Kintner, D. B., Signore, A. P., Cao, G., and Chen, J. (2009). Calcium dysregulation induces apoptosis-inducing factor release: cross-talk between PARP-1-and calpain-signaling pathways. Exp. Neurol. 218, 213-220.
41. Wada, K., Chatzipanteli, K., Kraydieh, S., Busto, R., and Dietrich, W. D. (1998). Inducible nitric oxide synthase expression after traumatic brain injury and neuroprotection with ami-noguanidine treatment in rats. Neurosurgery 43, 1427-1436. (Pubitemid 28545874)
42. Wang, G. H., Zhang, X. G., Jiang, Z. L., Li, X., Peng, L. L., Li, Y. C., and Wang, Y. (2010). Neuroprotective effects of hyperbaric oxygen treatment on traumatic brain injury in the rat. J. Neurotrauma 27, 1733-1743.
43. Watanabe, T., Morita, I., Nishi, H., Murota, S. (1988). Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostaglandins Leukot. Essent. Fatty Acids 33, 81-87.
44. Yoshida, H., Yanai, H., Namiki, Y., Fukatsu-Sasaki, K., Furutani, N., and Tada, N. (2006). Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev. 12, 9-20. (Pubitemid 44133577)
45. Zhang, N., Komine-Kobayashi, M., Tanaka, R., Liu, M., Mizuno, Y., and Urabe, T. (2005). Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36, 2220-2225. (Pubitemid 41429250)
46. Ziebell, J. M., and Morganti-Kossmann, M. C. (2010). Involvement of pro-and anti-inflammatory cytokines and chemo-kines in the pathophysiology of traumatic brain injury. Neurotherapeutics 7, 22-30.